Profile | GDS4284 / 201847_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 9217.65 | 97 |
GSM687648 | Patient 402 control | 10180.2 | 97 |
GSM687653 | Patient 403 control | 8664.84 | 96 |
GSM687658 | Patient 404 control | 6461.9 | 95 |
GSM687663 | Patient 411 control | 6554.12 | 95 |
GSM687668 | Patient 422 control | 8623.8 | 96 |
GSM687673 | Patient 424 control | 8584.48 | 96 |
GSM687678 | Patient 425 control | 7848.13 | 96 |
GSM687683 | Patient 427 control | 8183.22 | 96 |
GSM687688 | Patient 428 control | 6070.08 | 95 |
GSM687695 | Patient 441 control | 8470.32 | 96 |
GSM687699 | Patient 443 control | 9196.74 | 97 |
GSM687704 | Patient 444 control | 6907.78 | 95 |
GSM687707 | Patient 448 control | 7073.5 | 96 |
GSM687712 | Patient 449 control | 9244.72 | 97 |
GSM687719 | Patient 450 control | 7702.81 | 96 |
GSM687724 | Patient 451 control | 10864.4 | 97 |
GSM687728 | Patient 452 control | 8119.12 | 96 |
GSM687646 | Patient 401 treated 24h | 7285.15 | 96 |
GSM687649 | Patient 402 treated 24h | 9343.12 | 97 |
GSM687665 | Patient 411 treated 24h | 7611.73 | 96 |
GSM687651 | Patient 402 treated 4 weeks | 10439.8 | 97 |
GSM687667 | Patient 411 treated 4 weeks | 6471.36 | 95 |
GSM687670 | Patient 422 treated 24h | 7967.79 | 96 |
GSM687671 | Patient 422 treated 4 weeks | 8019.31 | 96 |
GSM687654 | Patient 403 treated 24h | 9239.4 | 97 |
GSM687675 | Patient 424 treated 24h | 8627.47 | 97 |
GSM687685 | Patient 427 treated 24h | 10131.2 | 97 |
GSM687656 | Patient 403 treated 4 weeks | 8655.59 | 96 |
GSM687677 | Patient 424 treated 4 weeks | 7122.15 | 96 |
GSM687687 | Patient 427 treated 4 weeks | 9721.42 | 97 |
GSM687692 | Patient 428 treated 4h | 5586.58 | 94 |
GSM687716 | Patient 449 treated 4h | 10018.3 | 97 |
GSM687722 | Patient 450 treated 4h | 7278.92 | 96 |
GSM687680 | Patient 425 treated 24h | 8563.59 | 97 |
GSM687690 | Patient 428 treated 24h | 5727.2 | 94 |
GSM687700 | Patient 443 treated 24h | 8141.28 | 96 |
GSM687705 | Patient 444 treated 24h | 6135.59 | 95 |
GSM687714 | Patient 449 treated 24h | 8702.36 | 96 |
GSM687721 | Patient 450 treated 24h | 7761.43 | 96 |
GSM687682 | Patient 425 treated 4 weeks | 7580.88 | 96 |
GSM687694 | Patient 428 treated 4 weeks | 6032.13 | 95 |
GSM687702 | Patient 443 treated 4 weeks | 8254.39 | 96 |
GSM687718 | Patient 449 treated 4 weeks | 9163.76 | 97 |
GSM687723 | Patient 450 treated 4 weeks | 9088.19 | 97 |
GSM687661 | Patient 404 treated 4h | 5896.15 | 95 |
GSM687710 | Patient 448 treated 4h | 8208.89 | 96 |
GSM687726 | Patient 451 treated 4h | 9368.52 | 97 |
GSM687730 | Patient 452 treated 4h | 2198.12 | 87 |
GSM687660 | Patient 404 treated 24h | 3984.34 | 92 |
GSM687697 | Patient 441 treated 24h | 8453.99 | 96 |
GSM687709 | Patient 448 treated 24h | 6659.03 | 95 |
GSM687725 | Patient 451 treated 24h | 9160.17 | 97 |
GSM687729 | Patient 452 treated 24h | 10683.3 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 7904.72 | 96 |
GSM687731 | Patient 452 treated 4 weeks | 9651.15 | 97 |